News Aug 18, 2021 Debiopharm launches IDEAL, a new hub for life sciences Biopharmaceutical company Debiopharm has launched the “IDEAL” initiative to strengthen the Western Switzerland region as a hub for life science i...
News Jan 22, 2024 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
News Jan 19, 2024 Basel-Stadt expands innovation promotion The canton of Basel-Stadt is increasing its innovation funding to a total of 67 million Swiss francs by 2030. Existing programs such as BaseLaunc...
Aktuell Jun 22, 2023 MSD weiht neues Forschungslabor in Schachen ein MSD Merck Sharp & Dohme (MSD) hat am Standort Schachen ein neues Forschungslabor eingeweiht. Dafür hat MSD 20 Millionen Franken investiert. Künft...
Aktuell Jun 09, 2023 UZH übernimmt Pionierrolle für One Health Drei Fakultäten der Universität Zürich (UZH) haben gemeinsam das erste One Health Institute an einer europäischen Universität gegründet. Veterinä...
News Jan 17, 2024 Spiden makes a breakthrough in non-invasive glucose measurements Spiden has made significant progress in the area of non-invasive glucose measurements. The company hopes to develop a wearable device on the basi...
News Jan 19, 2024 Soldering to be used to close wounds Empa researchers, working together with the Swiss Federal Institute of Technology in Zurich, have developed a new method of closing wounds. The p...
News Dec 02, 2020 Biopharmaceutical giant Lonza to build two new production lines and create 200 new jobs in Valais Following a long-term strategic agreement in the field of bioconjugates with a global biopharmaceutical company, Lonza will build two new product...
News Jan 12, 2024 Gilde Healthcare acquires majority stake in Swiss Dental Solutions Gilde Healthcare is the new majority shareholder of Swiss Dental Solutions AG, which specializes in biological dentistry. Founder and former owne...
News May 10, 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...
News Apr 27, 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...
News May 18, 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
Aktuell Aug 08, 2023 Do Tank Aargau soll Life Sciences-Branche stärken Mit dem Pilotprojekt Do Tank Aargau stärken der Kanton Aargau, die Stadt Baden und das Kantonsspital Baden (KSB) die Life Sciences-Branche im Kan...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Jan 09, 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...
Aktuell May 23, 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...